FROM SERUM DYSLIPIDEMIA TO MACROPHAGE LIPID REMODELING IN VISCERAL LEISHMANIASIS: CHOLESTEROL TRAFFICKING, IMMUNOMETABOLIC REPROGRAMMING, AND THERAPEUTIC OPPORTUNITIES. ISIR Journal of Business and Management Studies (ISIRJBMS), v. 3, n. 5, p. 45–55, 31 Oct.2026.